Research summary, regulation or standard, 2015

EU BSS Summary for Health Professionals

European Society of Radiology (ESR). Insights into imaging. 2015

Read the original paper

In plain language

The 2013 EU Basic Safety Standards Directive lowered the occupational eye lens dose limit from 150 to 20 mSv per year and requires monitoring, pregnancy protections and optimisation of staff dose for the fluoroscopy team in interventional work.

At a glance

Type of study
Regulation or standard
Who was studied
Interventional radiologists, Radiologic technologists, Medical physicists and radiation safety officers, Other physicians, Trainees, Patients
Where
European Union
Summary based on
the full text

What it found

  • The occupational eye lens dose limit was lowered from 150 mSv/year to 20 mSv/year.

    Key figures: 20 mSv/year (previously 150 mSv/year)

  • The eye lens limit may be averaged as 100 mSv over 5 years with a 50 mSv single-year maximum; the effective dose limit is 20 mSv/year.

    Key figures: 100 mSv in 5 years, max 50 mSv in a single year

  • Workers who may exceed 15 mSv/year to the eye lens, 6 mSv effective dose or 150 mSv to skin/extremities must be classed Category A, with individual monitoring and medical surveillance.

    Key figures: 6 mSv effective; 15 mSv lens; 150 mSv skin/extremities

  • Once a worker declares pregnancy, the dose to the unborn child must be as low as reasonably achievable (ALARA) and unlikely to exceed 1 mSv for the rest of the pregnancy.

    Key figures: 1 mSv

  • Occupational exposure from medical practices must be considered in optimisation, and a medical physics expert must be involved in interventional radiology.

Limits to keep in mind

This is a descriptive summary of a regulatory directive, not an empirical study, so it provides no data on doses or health outcomes.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.